Telix 2024 Full Year Results: Record Financial Performance and Investment in Future Growth, FY2025 Guidance of up to $1.23 Billion
Telix has also provided R&D expenditure guidance, expecting an increased investment range of 20% to 25% compared to FY2024. An investor webcast will be held at 9.00am AEDT on Friday 21 February 2025 ...
Amplitude (AMPL) Q4 2024 Earnings Call Transcript
Welcome to Amplitude's fourth quarter and full year 2024 earnings call. I'm John Streppa, head of investor relations. Joining ...
Zealand Pharma Announces Financial Results for the Full Year 2024
No. 2 / 2025Zealand Pharma Announces Financial Results for the Full Year 2024A transformational year with significant ...
Dynavax Technologies (DVAX) Q4 2024 Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Dynavax Technologies fourth quarter and full year 2024 financial results ...
Gene Therapy Market to Hit USD 36.55 Billion by 2032 with 19.4% CAGR | MarketsandMarkets™.
The global Gene Therapy market, valued at US$7.21 billion in 2023, is forecasted to grow at a robust CAGR of 19.4%, reaching ...